mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |